Literature DB >> 7941349

The role of the E1 and E2 proteins in the replication of human papillomavirus type 31b.

M G Frattini1, L A Laimins.   

Abstract

Using transient assays, the cis and trans requirements for human papillomavirus type 31b (HPV-31b) replication in transformed and primary keratinocytes have been determined. We demonstrate that expression of both the E1 and E2 open reading frames are necessary and sufficient for replication of a plasmid construct containing a genomic 291-bp fragment in both cell types. The roles of the E1 and E2 proteins in replication were further examined by overexpressing the gene products in a glutathione-S-transferase bacterial expression system. In addition to a full-length E1 protein, a truncated E1 protein (E1*) which consisted of the amino-terminal 268 aa was synthesized. Both E1 and E1* were found to complex efficiently with the E2 protein in vivo and in vitro. In addition, site-specific DNA binding by both the E2 and E1 proteins to HPV-31b origin containing DNA was observed. The E1* protein, however, failed to bind HPV-31b DNA specifically and could not cooperate with E2 for replication in transient assays. DNase I footprinting demonstrated that the E1 protein of HPV-31b bound to an A/T-rich region (nucleotides 7905-24) which shares similarities with the binding site for the bovine papillomavirus type 1 (BPV-1) E1 protein. These studies describe both similarities and differences in the requirements for replication of HPV-31b and BPV-1.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7941349     DOI: 10.1006/viro.1994.1596

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  50 in total

1.  Inhibition of human papillomavirus DNA replication by an E1-derived p80/UAF1-binding peptide.

Authors:  Michaël Lehoux; Amélie Fradet-Turcotte; Mathieu Lussier-Price; James G Omichinski; Jacques Archambault
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  Differential effects of the splice acceptor at nucleotide 3295 of human papillomavirus type 31 on stable and transient viral replication.

Authors:  D J Klumpp; F Stubenrauch; L A Laimins
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  E1-mediated recruitment of a UAF1-USP deubiquitinase complex facilitates human papillomavirus DNA replication.

Authors:  Michaël Lehoux; David Gagnon; Jacques Archambault
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

4.  Development of quantitative and high-throughput assays of polyomavirus and papillomavirus DNA replication.

Authors:  Amélie Fradet-Turcotte; Geneviève Morin; Michaël Lehoux; Peter A Bullock; Jacques Archambault
Journal:  Virology       Date:  2010-01-15       Impact factor: 3.616

5.  Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions.

Authors:  F Stubenrauch; A M Colbert; L A Laimins
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

6.  The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms.

Authors:  Kirsten Kabsch; Angel Alonso
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

7.  Long-term effect of interferon on keratinocytes that maintain human papillomavirus type 31.

Authors:  Yijan E Chang; Loren Pena; Ganes C Sen; Jung K Park; Laimonis A Laimins
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification.

Authors:  M A Ozbun; C Meyers
Journal:  Virology       Date:  1998-09-01       Impact factor: 3.616

9.  Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein.

Authors:  M G Frattini; L A Laimins
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

10.  DNA replication of human papillomavirus type 31 is modulated by elements of the upstream regulatory region that lie 5' of the minimal origin.

Authors:  W G Hubert; T Kanaya; L A Laimins
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.